Linda Peabody
Family · Duluth, GANPI 1104201417
Payments from drug & device makers
Across 129 payments — averaging $28.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$873
- AstraZeneca$487
- Astellas Pharma US Inc$372
- Lilly USA, LLC$258
- Amgen$163
- Biohaven Pharmaceutical Holding Company Ltd.$141
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,58698%
- Education$662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 29 | $873 |
| AstraZeneca | 11 | $487 |
| Astellas Pharma US Inc | 11 | $372 |
| Lilly USA, LLC | 9 | $258 |
| Amgen | 4 | $163 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $141 |
| AbbVie | 7 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $126 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| Abbott | 5 | $121 |
| Pfizer | 5 | $115 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
| Tris Pharma Inc | 5 | $94 |
| Exact Sciences | 3 | $62 |
| Lundbeck LLC | 2 | $56 |
| IBSA Pharma Inc. | 3 | $45 |
| Dexcom, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Antares Pharma, Inc. | 2 | $31 |
| VBI Vaccine (delaware) Inc. | 1 | $31 |
| Merck | 2 | $29 |
| Boehringer Ingelheim | 1 | $26 |
| Boston Scientific | 1 | $24 |
| GSK | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Noven Therapeutics, LLC | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Tolmar, Inc. | 1 | $14 |
| Linus Health, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Biogen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,652 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 65 | $68,316 |
| MounjaroTirzepatide | 39 | $48,304 |
| JardianceEmpagliflozin | 16 | $23,723 |
| FarxigaDapagliflozin Propanediol | 19 | $20,326 |
| Repatha SyringeEvolocumab | 11 | $6,215 |
| ProgesteroneProgesterone, Micronized | 57 | $3,328 |
| Testosterone | 13 | $2,632 |
| SynthroidLevothyroxine Sodium | 35 | $2,234 |
| Lidocaine | 17 | $1,971 |
| Armour ThyroidThyroid,pork | 13 | $1,965 |
| Levothyroxine Sodium | 227 | $1,683 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $1,355 |
| Rosuvastatin Calcium | 133 | $1,056 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $1,038 |
| Diclofenac Sodium | 21 | $979 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $873 | $68,31665 claims |
| Lilly USA, LLCMounjaro | $258 | $48,30439 claims |
| Boehringer IngelheimJardiance | $26 | $23,72316 claims |
| AstraZenecaFarxiga | $487 | $20,32619 claims |
| AbbVieSynthroid, Armour Thyroid | $128 | $4,19848 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.
Other family in Duluth
- Stephanie HigdonDuluth$28K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.